» Articles » PMID: 20095857

Synopsis of Partial-body Radiation Diagnostic Biomarkers and Medical Management of Radiation Injury Workshop

Abstract

Radiation exposures from accidents, nuclear detonations or terrorist incidents are unlikely to be homogeneous; however, current biodosimetric approaches are developed and validated primarily in whole-body irradiation models. A workshop was held at the Armed Forces Radiobiology Research Institute in May 2008 to draw attention to the need for partial-body biodosimetry, to discuss current knowledge, and to identify the gaps to be filled. A panel of international experts and the workshop attendees discussed the requirements and concepts for a path forward. This report addresses eight key areas identified by the Workshop Program Committee for future focus: (1) improved cytogenetics, (2) clinical signs and symptoms, (3) cutaneous bioindicators, (4) organ-specific biomarkers, (5) biophysical markers of dose, (6) integrated diagnostic approaches, (7) confounding factors, and (8) requirements for post-event medical follow-up. For each area, the status, advantages and limitations of existing approaches and suggestions for new directions are presented.

Citing Articles

Human cell-expressed tag-free rhMFG-E8 as an effective radiation mitigator.

Chaung W, Ma G, Jacob A, Brenner M, Wang P Sci Rep. 2023; 13(1):22186.

PMID: 38092894 PMC: 10719321. DOI: 10.1038/s41598-023-49499-y.


Biomarkers to Predict Lethal Radiation Injury to the Rat Lung.

Medhora M, Gao F, Gasperetti T, Narayanan J, Himburg H, Jacobs E Int J Mol Sci. 2023; 24(6).

PMID: 36982722 PMC: 10053311. DOI: 10.3390/ijms24065627.


Prediction of Total-Body and Partial-Body Exposures to Radiation Using Plasma Proteomic Expression Profiles.

Sproull M, Kawai T, Krauze A, Shankavaram U, Camphausen K Radiat Res. 2022; 198(6):573-581.

PMID: 36136739 PMC: 9896586. DOI: 10.1667/RADE-22-00074.1.


Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient Management.

Satyamitra M, Reyes Turcu F, Pantoja-Galicia N, Wathen L Radiat Res. 2021; 196(5):455-467.

PMID: 34143223 PMC: 9923779. DOI: 10.1667/RADE-21-00072.1.


Validation of a biomarker tool capable of measuring the absorbed dose soon after exposure to ionizing radiation.

Giovanetti A, Marconi R, Awad N, Abuzied H, Agamy N, Barakat M Sci Rep. 2021; 11(1):8118.

PMID: 33854097 PMC: 8047015. DOI: 10.1038/s41598-021-87173-3.


References
1.
Meadows S, Dressman H, Muramoto G, Himburg H, Salter A, Wei Z . Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One. 2008; 3(4):e1912. PMC: 2271127. DOI: 10.1371/journal.pone.0001912. View

2.
Lataillade J, Doucet C, Bey E, Carsin H, Huet C, Clairand I . New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med. 2007; 2(5):785-94. DOI: 10.2217/17460751.2.5.785. View

3.
Marsit C, Eddy K, Kelsey K . MicroRNA responses to cellular stress. Cancer Res. 2006; 66(22):10843-8. DOI: 10.1158/0008-5472.CAN-06-1894. View

4.
Ossetrova N, Sandgren D, Gallego S, Blakely W . Combined approach of hematological biomarkers and plasma protein SAA for improvement of radiation dose assessment triage in biodosimetry applications. Health Phys. 2010; 98(2):204-8. DOI: 10.1097/HP.0b013e3181abaabf. View

5.
Hill R, Kaspler P, Griffin A, OSullivan B, Catton C, Alasti H . Studies of the in vivo radiosensitivity of human skin fibroblasts. Radiother Oncol. 2007; 84(1):75-83. PMC: 2034367. DOI: 10.1016/j.radonc.2007.05.025. View